Literature DB >> 6788770

A novel phosphorylcholine-binding protein from rat serum and its effect on heparin-lipoprotein complex formation in the presence of calcium.

A Nagpurkar, S Mookerjea.   

Abstract

An adsorbent was synthesized by attaching 4-aminophenylphosphorylcholine to cyanogen bromide-activated Sepharose. A phosphorylcholine (P-choline)-binding protein from rat serum was adsorbed on this affinity column which was eluted by 4 mM P-choline. The protein separated into two bands of Mr = 47,000 and 24,000 on sodium dodecyl sulfate-polyacrylamide gradient gels and contained 18% carbohydrate. A serum protein factor, precipitable by 30-50% (NH4)2SO4, was previously shown to inhibit Ca2+-heparin-rat serum very low density lipoprotein (VLDL) precipitation reaction, whereas P-choline counteracted the action of this protein (Mookerjea, S. (1978) Can. J. Biochem. 56, 746-752). It is now demonstrated that purified P-choline-binding protein prevents Ca2+-heparin-chylomicron or VLDL complex formation and P-choline reverses the effect of this protein. Antibody to P-choline-binding protein raised in rabbits produced a single precipitin line against the pure antigen. The antiserum, however, did not react against rat serum chylomicron, VLDL, low density lipoproteins, or high density lipoprotein. Human serum appears to lack P-choline-binding protein, since (a) the affinity column did not adsorb any such protein, (b) P-choline had no effect on the Ca2+-heparin-serum lipoprotein precipitation reaction, and (c) an immunodiffusion test against the antiserum was negative. However, when P-choline-binding protein was added to human serum, the lipoprotein precipitation was inhibited, and P-choline counteracted the effect of this protein. Preliminary experiments suggested a stoichiometric interaction between P-choline-binding protein and VLDL. Hydrophilic P-choline groups exposed on the surface of VLDL may possibly interact with the P-choline-binding protein and thereby affect the precipitation of lipoproteins by heparin and Ca2+.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6788770

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Modulation of sialic acid-binding proteins of rat uterus in response to changing hormonal milieu.

Authors:  I Chakraborty; C Mandal; M Chowdhury
Journal:  Mol Cell Biochem       Date:  1993-09-08       Impact factor: 3.396

2.  Role of C-reactive protein in complement-mediated hemolysis in Malaria.

Authors:  Waliza Ansar; Sumi Mukhopadhyay Nee Bandyopadhyay; Suchandra Chowdhury; Sk Hasan Habib; Chitra Mandal
Journal:  Glycoconj J       Date:  2006-05       Impact factor: 2.916

3.  Effect of auranofin on plasma fibronectin, C reactive protein, and albumin levels in arthritic rats.

Authors:  K M Connolly; V J Stecher; D J Pruden
Journal:  Ann Rheum Dis       Date:  1988-06       Impact factor: 19.103

4.  C-reactive protein and apoB containing lipoproteins are associated with Mycobacterium leprae in lesions of human leprosy.

Authors:  M J Ridley; D S Ridley; F C De Beer; M B Pepys
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

5.  Degradation of rat C-reactive protein by macrophages.

Authors:  A Nagpurkar; D Hunt; C Y Yang; S Mookerjea
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

6.  Variations in binding characteristics of glycosylated human C-reactive proteins in different pathological conditions.

Authors:  Tanusree Das; Chhabinath Mandal; Chitra Mandal
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

Review 7.  C-reactive protein and the biology of disease.

Authors:  Waliza Ansar; Shyamasree Ghosh
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

8.  Carbohydrate-binding profile of a pregnancy-associated rat uterine glycoprotein.

Authors:  M Das; P K Mukhopadhyay; M Chowdhury
Journal:  Mol Cell Biochem       Date:  1994-08-31       Impact factor: 3.396

9.  Alteration of interleukin-1 activity and the acute phase response in adjuvant arthritic rats treated with disease modifying antirheumatic drugs.

Authors:  K M Connolly; V J Stecher; E Danis; D J Pruden; T LaBrie
Journal:  Agents Actions       Date:  1988-08

10.  The regulation of superoxide generation and nitric oxide synthesis by C-reactive protein.

Authors:  S Ratnam; S Mookerjea
Journal:  Immunology       Date:  1998-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.